Correlation Between Entrada Therapeutics and Victrex Plc

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Victrex Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Victrex Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and Victrex plc, you can compare the effects of market volatilities on Entrada Therapeutics and Victrex Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Victrex Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Victrex Plc.

Diversification Opportunities for Entrada Therapeutics and Victrex Plc

-0.74

Correlation Coefficient

Entrada Therapeutics  Victrex Plc

Pay attention - limited upside

The 3 months correlation between Entrada and Victrex is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Victrex plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Victrex plc and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Victrex Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Victrex plc has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Victrex Plc go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Victrex Plc

Given the investment horizon of 90 days Entrada Therapeutics is expected to under-perform the Victrex Plc. But the stock apears to be less risky and, when comparing its historical volatility, Entrada Therapeutics is 1.82 times less risky than Victrex Plc. The stock trades about -0.16 of its potential returns per unit of risk. The Victrex plc is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  1,026  in Victrex plc on September 28, 2024 and sell it today you would earn a total of  298.00  from holding Victrex plc or generate 29.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Entrada Therapeutics  vs.  Victrex plc

Entrada Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Victrex plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Victrex plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Victrex Plc is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Entrada Therapeutics and Victrex Plc

The main advantage of trading using opposite Entrada Therapeutics and Victrex Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Victrex Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Victrex Plc will offset losses from the drop in Victrex Plc's long position.

The idea behind Entrada Therapeutics and Victrex plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.